ID: ALA4874609

Max Phase: Preclinical

Molecular Formula: C18H15N3O2

Molecular Weight: 305.34

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1c(C)nc2n(-c3ccccc3)c3ccccc3n12

Standard InChI:  InChI=1S/C18H15N3O2/c1-12-16(17(22)23-2)21-15-11-7-6-10-14(15)20(18(21)19-12)13-8-4-3-5-9-13/h3-11H,1-2H3

Standard InChI Key:  PIXVUWYYCQHLGD-UHFFFAOYSA-N

Associated Targets(Human)

Transient receptor potential cation channel subfamily M member 2 348 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 305.34Molecular Weight (Monoisotopic): 305.1164AlogP: 3.37#Rotatable Bonds: 2
Polar Surface Area: 48.53Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.07CX LogP: 3.00CX LogD: 3.00
Aromatic Rings: 4Heavy Atoms: 23QED Weighted: 0.53Np Likeness Score: -1.12

References

1. Zhao S, Zhang H, Jin H, Cai X, Zhang R, Jin Z, Yang W, Yu P, Zhang L, Liu Z..  (2021)  Design, synthesis and biological activities of benzo[d]imidazo[1,2-a]imidazole derivatives as TRPM2-specfic inhibitors.,  225  [PMID:34416664] [10.1016/j.ejmech.2021.113750]

Source